Blood Vial

Dillon Steyl · 2026 · $4.99 · Action · deal grade C

• Estimated net residual revenue: $3.4k to $5.1k per month
• Opportunity: $4.2k per month at x1.00 dormancy
• Estimated lifetime owners: 10.0k
• 96%% positive across 334 reviews · 101.3 reviews/month

Why it's flagged

• Developer active, last post 4 months ago
• Studio active elsewhere (2 titles tracked), so this one may welcome a partner
• Last build shipped 4 months ago
• Store page localized in only 1 language(s)
• Last discounted 0 months ago, 3 sales in the last 12 months

This case as Markdown · Estimates carry ±30-50%% error per title.